ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

September 14, 2012

Rogers Eyes Saccharin Ban

March 18, 1977